BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18339871)

  • 1. Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
    Bulk E; Hascher A; Liersch R; Mesters RM; Diederichs S; Sargin B; Gerke V; Hotfilder M; Vormoor J; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2008 Mar; 68(6):1896-904. PubMed ID: 18339871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A2 induces metastasis in non-small cell lung cancer.
    Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
    Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
    Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
    Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
    Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.
    Kamlah F; Eul BG; Li S; Lang N; Marsh LM; Seeger W; Grimminger F; Rose F; Hänze J
    Cancer Gene Ther; 2009 Mar; 16(3):195-205. PubMed ID: 18818708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
    Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
    J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
    Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
    Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
    Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
    Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
    Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
    Stabile LP; Lyker JS; Huang L; Siegfried JM
    Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
    Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
    Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
    Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
    Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
    Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
    Du XL; Jiang T; Sheng XG; Gao R; Li QS
    Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.
    Moncho-Amor V; Ibañez de Cáceres I; Bandres E; Martínez-Poveda B; Orgaz JL; Sánchez-Pérez I; Zazo S; Rovira A; Albanell J; Jiménez B; Rojo F; Belda-Iniesta C; García-Foncillas J; Perona R
    Oncogene; 2011 Feb; 30(6):668-78. PubMed ID: 20890299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo.
    Howard BA; Furumai R; Campa MJ; Rabbani ZN; Vujaskovic Z; Wang XF; Patz EF
    Cancer Res; 2005 Oct; 65(19):8853-60. PubMed ID: 16204056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.